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UV-Mediated Gene Expression
Yang et al. identified potential genes 
that participate in the melanocytic 
response to ultraviolet radiation 
(UVR). Using primary melanocyte 
cultures to assess for alterations in 
over 47,000 transcripts, they identi-
fied the 100 most statistically robust 
changes in transcript level; 84 genes 
were suppressed, and 99 genes were 
induced, more than twofold by UVR. 
About half the genes were novel tran-
scripts. Further analysis showed that a 
group of select p53 target genes were 
also consistently elevated by UVR. The specific identity of these genes generates new 
avenues for investigation in the UVR biology of melanocytes and possibly melanoma 
tumorigenesis. See page 2490 
Harlequin Gene Unmasked
Thomas et al. have shown 
previously that mutations 
in the ABCA12 gene, 
encoding an ATP-bind-
ing cassette (ABC) trans-
porter, underlie the skin 
disease harlequin ichthy-
osis (HI). A multinational 
team of investigators has 
now sequenced the ABCA12 gene in an additional 14 patients. All show the muta-
tions; the majority are either nonsense substitution or frameshift mutations. Eleven 
HI patients had biallelic ABCA12, and in the other three patients, ABCA12 mutations 
were detected on only one allele. These mutation data firmly establish ABCA12 as the 
major HI gene. See page 2408 
Measles Kills CTCL
Measles virus (MV) has shown promise as 
an oncolytic virus in the treatment of tumor 
models including cutaneous T-cell lympho-
ma (CTCL). Künzi and colleagues investi-
gated the effect of a recombinant MV (rMV) 
vaccine strain in CTCL cell cultures and 
in vivo in CTCL xenografts in nude mice. 
In those mice, intratumoral injection of 
rMV induced complete regression of large 
established human CTCL tumors, whereas 
control-treated tumors progressed exponen-
tially. Analysis of tumor biopsies after intra-
tumoral treatment demonstrated replication of MV within the tumors. MV appears to 
have potential as a therapeutic agent against CTCL. See page 2525 
Psoriatic Plaque 
Phenotype (PPP)
The 500 participants in the 
Utah Psoriasis Initiative self-
assessed plaque thickness 
when their disease was at its 
worst. Preliminary evidence 
showed that plaque thickness is 
an easily measured trait linked 
with other clinical features of 
psoriasis: thick plaques are 
associated with male gender, 
increased body mass index, 
nail disease, psoriatic arthritis, 
larger plaques, more body 
sites and greater total body 
surface area affected. Thin 
plaques are associated with 
eczema, guttate psoriasis, 
and skin cancer. Christensen 
and colleagues suggest that 
stratification on this phenotype 
may be useful in further 
defining the genetic basis of 
psoriasis. See page 2397
It’s the Fetus, Not 
the Mother
Pittman and colleagues used 
several molecular genetic 
techniques to explore 
whether hemangioma 
endothelial cells (HECs) were 
maternal in origin. Their 
analyses revealed that in 
seven informative mother–
child pairs, HECs matched 
the genotype of the child. In 
an enriched cell population, 
again only the genotype 
of the child was exhibited. 
The authors concluded that 
the phenotype is not due to 
any maternal component 
represented in the tumor, 
and therefore the clonal 
expansion of endothelial cells 
in the tumor stems from the 
fetus. See page 2533
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